Mammoth Biosciences

Mammoth Biosciences is a company that specializes in the development of a CRISPR-based detection platform for disease detection. Their platform is designed to provide an efficient and affordable point-of-need test that can rapidly detect multiple conditions simultaneously. This technology is aimed at democratizing molecular diagnostics and making them accessible to healthcare providers, researchers, and biotech professionals. The company’s focus is on creating a new standard for disease detection that is fast, accurate, and accessible to everyone.